13D/13G Filings - Viracta Therapeutics Inc. (VIRX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-01-07
08:39 am
Unchanged
2020-12-3113GSUNESIS PHARMACEUTICALS INC CO
SNSS
SABBY MANAGEMENT LLC0
0.000%
0
(Unchanged)
Filing
History
2021-01-04
12:35 pm
Purchase
2020-12-2213GSUNESIS PHARMACEUTICALS INC CO
SNSS
LYTTON LAURENCE W1,598,519
8.800%
1,598,519increase
(New Position)
Filing
History
2020-08-07
2:51 pm
Purchase
2020-07-2913GSUNESIS PHARMACEUTICALS INC CO
SNSS
Ayrton Capital LLC10,869,565
6.650%
10,869,565increase
(New Position)
Filing
History
2020-08-03
10:18 am
Purchase
2020-07-2913GSUNESIS PHARMACEUTICALS INC CO
SNSS
CVI Investments, Inc.8,695,652
5.300%
8,695,652increase
(New Position)
Filing
History
2020-07-29
11:06 am
Purchase
2020-07-2913GSUNESIS PHARMACEUTICALS INC CO
SNSS
SABBY MANAGEMENT LLC10,869,565
11.000%
10,869,565increase
(New Position)
Filing
History
Goto Prev, 0, 1